Patient Case Report : Memantine for the Treatment of Occipital Neuralgia

for Clinical neuropharmacology | (18.09.2020)

by Hayes, W. | Hoffmann, C. | Jacobson, P. | +3

Sumatriptan improves the locomotor activity and neuropathic pain by modulating neuroinflammation in rat model of spinal cord injury

for Neurological research | (16.09.2020), p. 1-11

by Afshari, K. | Dehdashtian, A. | Haddad, N. | +9

Onset of action in placebo-controlled migraine attacks trials : A literature review and recommendation

for Cephalalgia | (09.09.2020), p. 333102420956916

by Tfelt-Hansen, P. | Diener, H.

Cyproheptadine in the treatment of reversible cerebral vasoconstriction syndrome

for Acta neurologica Belgica | (08.09.2020)

by Chima, J. | Mullaguri, N. | Fan, T. | +2

Cluster headache not responsive to sumatriptan : A retrospective study

for Cephalalgia | (03.09.2020), p. 333102420956705

by Giani, L. | Cecchini, A. | Astengo, A. | +2

Nose-to-brain delivery of sumatriptan-loaded nanostructured lipid carriers : preparation, optimization, characterization and pharmacokinetic evaluation

for The Journal of pharmacy and pharmacology | Vol. 72, No. 10 (2020), p. 1341-1351

by Masjedi, M. | Azadi, A. | Heidari, R. | +1

Identifying common pharmacotherapies associated with reduced COVID-19 morbidity using electronic health records

for bioRxiv.org | (2020) vom: 28. Aug.

by Castro, V. | Ross, R. | McBride, S. | +1

Full text access (free access) 10.1101/2020.04.11.20061994

Vasospasm induced myocardial ischaemia secondary to sumatriptan use

for BMJ case reports | Vol. 13, No. 8 (2020)

by Okonkwo, K. | Ojha, U.

Inflammation induces developmentally regulated sumatriptan inhibition of spinal synaptic transmission

for British journal of pharmacology | Vol. 177, No. 16 (2020), p. 3730-3743

by Winters, B. | Jeong, H. | Vaughan, C.

Evaluation of LY573144 (lasmiditan) in a preclinical model of medication overuse headache

for Cephalalgia | Vol. 40, No. 9 (2020), p. 903-912

by Rau, J. | Navratilova, E. | Oyarzo, J. | +5